Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series.
Anne K EllisLori ConnorsMarie-Josee FrancoeurDouglas P MackPublished in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2021)
In the cases presented, treatment with rupatadine resolved LAR associated with SLIT-T treatment and rupatadine pretreatment appeared to mitigate subsequent LAR. Rupatadine may be an option to treat or improve the tolerability of the SLIT-T, potentially improving early treatment persistence.